Nephrology Dialysis Transplantation

Article	Citations
Correction to: CKD therapy to improve outcomes of immune-mediated glomerular diseases	217
Phosphorus balance calculator: an individualized tool for treatment of hyperphosphatemia in hemodialysis patients	200
Immunoengineering for autoimmune-kidney disease	137
Anti-C1Q monitoring predicts relapses of lupus nephritis	120
#1237 Management of dyslipidaemia with evolocumab in kidney transplant recipients	119
#3055 Replacement of tunneled cuffed hemodialysis catheters on coated guidewire: a strategic approach to treat CVC-related infections	92
#4264 PERITONEAL DIALYSIS AFTER FAILED KIDNEY TRANSPLANT: A SUITABLE OPTION	87
#2387 Case study of a patient with gouty nephropathy treated with immunosorbent therapy	86
#606 Impact of real-world off-label dose of apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease	85
#4176 ROLE OF KIDNEY FUNCTION ON NRF2 MRNA LEVELS IN TYPE-2 DIABETES	71
#802 CENSUS-EU: a cross-sectional, study to assess the prevalence and burden of chronic kidney disease-associated pruritus in Europe	70
#3140 Investigating the impact of Anti-IL5 therapy in eosinophilic granulomatosis with polyangiitis (EGPA): a three year longitudinal perspective	67
#6120 MIRNA PROFILING OF URINARY EXTRACELLULAR VESICLES (EVS) IN TBMN AND CFHR5 NEPHROPATHY FOR THE IDENTIFICATION OF NOVEL DISEASE BIOMARKERS	65
#675 Application of ANCA-associated vasculitis Histopathological Classification and Renal Risk Score for prediction of end-stage kidney disease	63
#3968 DIFFERENCES IN MENTAL HEALTH STATUS DURING COVID-19 PANDEMIC BETWEEN IN-CENTER HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS	62
#3144 KIDNEY TRANSPLANT-RELATED KNOWLEDGE AMONG SOUTH ASIAN COMPARED TO WHITE CANADIAN PATIENTS	60
#2294 Muscle ultrasound as a tool for morphofunctional assessment in patients with chronic kidney disease	58
#6279 ESKD TREATMENTS: A DIFFICULT CHOICE TO ELDERLY PATIENTS?	56
#1818 Association of combined systemic inflammatory indices with the severity and outcome of tunnelled hemodialysis catheter-related bacteremia	55
#4585 POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER: COMPARISON OF RISK AND PROGNOSTIC FACTORS BETWEEN KIDNEY AND OTHER ORGAN TRANSPLANT RECIPIENTS	55
#2917 Desensitization techniques in ABO-incompatible renal transplantation: efficacy and analysis of complications	53
#5285 SERUM IRON AND NUTRITIONAL STATUS ARE ASSOCIATED IN PATIENTS WITH CHRONIC KIDNEY DISEASE	51
#1350 Finerenone in real-life clinical practice: first results from a pilot study	51
#2118 Monitoring hemodynamics in dialysis: on the feasibility of semi-continuous and multifrequency thoracic bioimpedance measurements by a wearable device	51
#3140 THE WEST OF SCOTLAND AND THROMBOTIC MICROANGIOPATHY	51

#2695 A Polycystin-1-Bicaudal C1 complex regulates focal adhesion function through integrin beta-1, F-actin organisation and local translation in HKE cells	50
#6368 PLATELET TO LYMPHOCYTE RATIO AND SICKLE CELL NEPHROPATHY	49
#1834 Prevalence of nephrolithiasis in patients with idiopathic hypercalciuria after two decades of follow-up	48
#6848 DIABETES AND HEMODIALYSIS ARTERIOVENOUS ACCESS CONSTRUCTION – A RETROSPECTIVE STUDY IN A SINGLE CENTER	47
#5730 PERLECAN AS A POTENTIAL BIOMARKER OF CARDIOVASCULAR RISK: ROLE OF ENDOTHELIAL GLYCOCALYX IN CHRONIC KIDNEY DISEASE	46
#5536 CIRCULATING LEVELS OF COPEPTIN, GROWTH DIFFERENTIATION FACTOR 15 (GDF15) AND INTERLEUKIN 6 (ILA-6) IN PATIENTS WITH ADVANCED KIDNEY DISEASE	46
#4127 MODULATION OF BLOOD PRESSURE THROUGH MICROBIOME EXCHANGE BETWEEN MILAN NORMOTENSIVE AND HYPERTENSIVE STRAINS OF RATS	46
#4720 SEPSIS, AKI AND MORTALITY. SEARCHING FOR NEW MARKERS: OUR EXPERIENCE WITH ENDOGENOUS OUABAIN	44
#3296 ADVERSE MUSCLE COMPOSITION ASSESSED BY MRI ASSOCIATES TO POOR FUNCTIONAL PERFORMANCE AND METABOLIC COMORBIDITIES IN CKD	44
#5349 CYCLIN D1 AMELIORATES ACUTE KIDNEY INJURY BY IMPROVING FATTY ACID OXIDATION VIA AMPK PATHWAY	44
#761 Effect of ketoanalogue-supplemented very low protein diet in the need to initiate renal replacement in chronic kidney disease patients	43
#3166 RECOGNITION OF RENAL TUBULAR DYSGENESIS IN ADOLESCENT CKD BY BIALLELIC AGT VARIANTS REQUIRED BROAD GENETIC ANALYSIS	43
#2531 AGATSTON INDEX AS A PREDICTOR OF PREDICTION OF THE DEGREE OF HEART VASCULAR DAMAGE IN STAGE 5 CKD PATIENTS RECEIVING PROGRAM HEMODIALYSIS	42
#5448 INCIDENCE OF ACUTE PULMONARY EDEMA AFTER THE SYSTEMATIC USE OF ULTRASOUND B-LINES	42
#3303 SUBOPTIMAL EXTENT OF RAASI RE-INITIATION AFTER DISCONTINUATION FOLLOWING HYPERKALEMIA: AN OBSERVATIONAL STUDY OF CARDIORENAL PATIENTS IN THE US AND JAPAN	42
#651 Diagnostiс criteria of the functional state of the kidneys in patients with type 2 diabetes mellitus	42
#3121 THE EFFECTIVENESS OF A GLUTEN-FREE DIET IN PATIENTS WITH IGA NEPHROPATHY	40
#2728 THROMBOINFLAMMATORY BIOMARKERS AND THEIR RELATIONSHIP WITH CIRCULATING GLYCOSAMINOGLYCANS IN END-STAGE RENAL DISEASE PATIENTS	40
#2251 Long-term systolic blood pressure variability as an independent risk factor for cardiovascular events in kidney transplant recipients	40
#1962 Development of triple-whammy induced pre-renal AKI is highly dependent on the hydration status	40
#1076 DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKCβ/ P66shc signaling pathway in diabetic kidney disease	40
#6005 COMPARISON OF SEMAGLUTIDE ORAL VS SUBCUTANEOUS IN CHRONIC KIDNEY DISEASE (CKD)	40
#1315 Management and long-term outcome of recurrent idiopathic FSGS in pediatric renal transplant recipients	40
#1795 Diverse histological findings of kidney injury in cancer patients on immunotherapy- impact on clinical management	39
#1846 Oxalate nephropathy in diabetic kidney disease: another factor to take into account?	38
#4063 APELIN INCREASES FOREARM BLOOD FLOW IN CHRONIC KIDNEY DISEASE	38
#635 Effect of multi-biomarker panels based on urinary N-terminal osteopontin on prediction of diabetic kidney disease in patients with diabetes mellitus	38
#2671 Renal tubular epithelial FFAR4 improves cellular senescence to alleviate interstitial fibrosis in CKD	38
#5510 CKD-ASSOCIATED PRURITUS SEVERITY AND ITS ASSOCIATION WITH BODY DISTRIBUTION AND EQ-5D HEALTH-RELATED QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS	38
#1716 IgA nephropathy: our center's experience	38
#5532 COVID-19 INFECTION MODIFIES GLOMERULAR DISEASE EVOLUTION	37
#1737 Kidney function, kidney function decline, and the risk of abdominal aortic aneurysm: the Stockholm CREAtinine Measurements (SCREAM) project	36
#972 A Novel Single Compound from Chinese Herbs as a Potential Candidate for Reducing obesity induced diabetic nephropathy via ATF3-RARRES1 axis pathway	35
#5785 ACUTE KIDNEY INJURY AS A RISK FACTOR FOR THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE AND MORTALITY IN HOSPITALIZED PATIENTS	35
#6891 MACHINE LEARNING NEPHROPATHOLOGY DIAGNOSTICS OF THROMBOTIC MICROANGIOPATHIES	35
#2529 The role of the circadian clock system in the transition from acute kidney injury to chronic kidney disease	35
#821 Kibra mediates the activation of hippo by classic signal pathway related to NPHP1 defect	34
#3641 DOES IBANDRONATE OR CALCIUM AND VITAMIN D MAINTAIN OR IMPROVE BONE MICROARCHITECTURE IN THE FIRST YEAR AFTER KIDNEY TRANSPLANTATION?	34
#2556 Therapeutic monitoring in patients with APRT deficiency using UPLC-MS/MS-based plasma assay	33
#3812 ARE KIDNEY CYSTS MORE COMMON IN PEOPLE WITH COL4A3/COL4A4 PATHOGENIC VARIANTS?	33
#4554 FRAX® ASSOCIATION, BONE DENSITOMETRY, BIOCHEMICAL PARAMETERS OF BONE MINERAL METABOLISM AND ADVANCED CHRONIC KIDNEY DISEASE	32
#2740 Pregnancy outcomes in patients with IgA nephropathy and the impact of pregnancy on the renal disease	32
#4758 IMPACT OF GENDER ON CHRONIC KIDNEY DISEASE IN ELDERLY	32
#3958 PROTON PUMP INHIBITORS AND THE RISK OF ACUTE KIDNEY INJURY IN PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS: A POPULATION-BASED COHORT STUDY	32
#5958 VALUE OF EXOME SEQUENCING “FIRST” FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE	32
#2963 Light chain deposition in the kidney is more frequent in patients with proliferative lupus nephritis	32
#6915 IMMUNOLOGIC EFFECTS OF THE DECREASE OF IMMUNOSUPPRESSION AFTER SARS-COV-2 INFECTION IN KIDNEY TRASPLANT RECIPIENTS	31
#814 Inflammatory biomarkers and progression of diabetic kidney disease	31
#2699 Rare glomerular microangiopathy: clinicopathological characteristics and prognosis	31
#860 The role of immunocorrection in the treatment of patients chronic pyelonephritis	31

#5142 THE NATURAL HISTORY OF FSGS IN THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) COHORT	30
#2439 The association between vitamin D deficiency and sarcopenia in patients with pre-dialysis CKD	30
#6456 DSA-NEGATIVE MICROVASCULAR INFLAMMATION IN KIDNEY TRANSPLANT BIOPSIES: GENE EXPRESSION COMPARISON WITH NATIVE AND TRANSPLANT KIDNEY CONTROLS	30
#543 Cognitive improvement in end stage renal disease patients post transplantation—a prospective observational study	30
#2868 PREDICTION OF MAJOR GASTROINTESTINAL BLEEDING EVENTS IN HEMODIALYSIS	30
#1704 GLP-1RA versus DPP-4 inhibitors and rates of hyperkalemia and discontinuation of renin-angiotensin system (RAS) blockade in Swedish routine care	30
#1839 Evaluating the severity of restless legs syndrome in chronic kidney disease patients across different renal replacement therapies	30
#2116 Socioeconomic position and incidence of chronic kidney disease in Central Italy	30
#3261 SAR131675, A SELECTIVE VEGFR3 INHIBITOR, AMELIORATES RENAL INFLAMMATION AND LYMPHANGIOGENESIS IN THE MURINE LUPUS NEPHRITIS MODEL	30
#2394 Inhibition of ACSS2-mediated H3K9 crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence	29
#5599 FEBUXOSTAT IN COMBINATION WITH ANAKINRA OR PH NEUTRALIZATION IMPROVE THE OUTCOMES IN HYPERURICEMIA-RELATED URIC ACID CRYSTALLURIA IN MICE	29
#1304 Clinical characteristics of acute kidney injury caused by Phytolaccaceae ingestion	29
#2450 Alternative splicing in podocytes under mechanical stress: a new perspective for the pathogenic effect of glomerular hypertension	29
#2685 SLC34A2 EXACERBATES TUBULAR INTERSTITIAL FIBROSIS VIA INDUCTION OF APOPTOSIS AND CELL CYCLE ARREST IN S PHASE	29
#6442 HOW CAN IT BE NEPHROANGIOSCLEROSIS? HE´S BEING TREATED ONLY WITH ONE ANTIHYPERTENSIVE DRUG	29
#5882 BENEFIT OF LONG-TERM TOLVAPTAN ADMINISTRATION ON KIDNEY DISEASE PROGRESSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A SINGLE-CENTRE EXPERIENCE	28
#2388 Relevance of anti-PLA2R levels in therapy decision and prediction of therapy outcome in patients with membranous nephropathy	28
#5645 SHORT-CHAIN FATTY ACIDS, PROPIONATE AND BUTYRATE, RESEMBLE THE BENEFICIAL EFFECTS OF VITAMIN D DURING ACUTE KIDNEY DAMAGE	28
#1297 Approaches to renal response assessment in rare monoclonal immunoglobulin related glomerulopathies	28
#1906 Lung ultrasound as a valid tool for fluid assessment in dialysis patients: a systematic review	28
#289 Lipocalin-2 promotes cardiovascular calcification in chronic kidney disease by upregulating STAT3/NCOA4-mediated ferritinophagy and ferroptosis	27
#6672 THE DEVELOPMENT OF A COMMUNITY-NEPHROLOGY, MULTI-DISCIPLINARY SERVICE	26
#1916 Infective endocarditis in young female hemodialysis patient: a case report and literature review	26
#6668 PREDICTION OF REMAINING RENAL FUNCTION IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY DUE TO RENAL TUMOUR MASS AND AFTER NEPHRECTOMY IN LIVING DONORS	26
#1914 Comprehensive single-cell sequencing and lipidomics identify diverse injury states and cholesterol dynamics of the PTs in AKI-to-CKD transition	26
#6896 A SCREENING AND CLINICAL MANIFESTATIONS OF FABRY DISEASE IN PATIENTS ATTENDING DIALYSIS AND NEPHROLOGY CLINICS IN DURBAN, SOUTH AFRICA	26
#1157 Body mass and fluid balance in dialysis: global profiles in Apollo Dial DB	25
#598 Successful application of allo-hemodialysis in a porcine model of embolization-induced acute kidney injury	25
#2649 Investigation of the Rac1-SGK1 pathway and therapeutic effects of finerenone and Rac1 inhibition in a Fabry disease podocyte model	25
#1281 Torque teno virus load in kidney transplantation: association with donor and recipient characteristics and clinical follow-up data	25
#2967 C-reactive protein/serum chloride ratio: a novel marker of all-cause mortality in prevalent chronic haemodialysis patients	25
#801 Impact of delayed graft function on cardiovascular events in kidney transplant recipients	25
#1063 Impact of geriatric nutritional risk index on renal function in elderly chronic kidney disease patients treated with SGLT2 inhibitors	25
#2745 New strategies for capturing undiagnosed chronic kidney disease in patients at risk	25
#1683 Gut permeability, circulating bacterial fragments, and left ventricular strain in peritoneal dialysis	25
#2550 Micro(nano)plastics in human urine: a surprising contrast between Chongqing's urban and rural regions	25
#672 Intradialytic hypotension and adverse symptoms are not related	25
#949 Vitamin K dependent proteins and bone quality in the first year after kidney transplantation	24
#2588 Renal trajectories in the french RaDiCo Alport syndrome cohort	24
#2398 Exogenous a-Klotho supplementation significantly prolongs survival in a mouse model of alport syndrome, with comparable outcomes to RASi	24
#2889 Changes in proteinuria and kidney function in subgroups of patients with IgAN defined by baseline Gd-IgA1 levels in a Phase 1/2 study of zigakibart	24
#3257 Urinary metabolomics in nephrotic syndrome: the experience of “Fondazione Policlinico Universitario A. Gemelli”	24
#2706 Genetically determined reduction of renal carbonic anhydrase 12 is associated with decreased kidney function and increased serum urate	24
#2590 Evolutionary origins of polycystic kidney disease genes: insights from emerging phylogenomic methodologies	24
#1881 Evaluating the clinical and economic impact of SGLT-2 inhibitors for CKD management in the UK: insights from the IMPACT CKD microsimulation model	24
#291 Prevalence and patterns of intradialytic arterial oxygen saturation instability: observations in a large U.S. hemodialysis cohort	24
#1796 The impact of metabolic syndrome components on renal function in patients with heart failure	23
#3134 Implementation of an iohexol-based GFR-measurement in clinical routine	23
#2638 Recombinant zoster vaccine (RZV) confers persistent immune responses with no safety concerns 4 to 8 years after vaccination of adults with renal transplant	23
#1922 Association of parathyroid hormone and alkaline phosphatase with fracture risk in patients with chronic kidney disease not on dialysis	23
#960 A single-centre service evaluation of patient-centred twice-weekly dialysis delivery	23
#3385 The short and long-term accuracy of urinary C-C motif Chemokine-14 in an ICU population	23
#3063 Real-world utility of the International IgA Nephropathy Prediction Tool in a tertiary referral centre of nephrology	23
#147 Evidence of impaired myocardial perfusion reserve in asymptomatic non-diabetic patients with advanced CKD	22
#1727 Kidney function associated with mortality in hantavirus infection: a cohort study in BRAZIL	22
#3268 Cognitive decline in hemodialysis patients : a prospective cross-sectional study analysing sociodemographic and clinical determinants	22
#2266 Integrating palliative care into nephrology: a single-center “action-research” process	22
#2271 SGLT2 inhibition triggers aestivation-like metabolic switches for water conservation in patients with heart failure—results from DAPA-Shuttle1, a randomized, placebo-controlled trial	22
#3777 Roles of antiHLA antibodies in the onset of MACE in a population of patients on dialysis and on the waiting list for kidney transplant. A retrospective single-center study	22
#2731 Legacy effect of pretransplant immunosuppression in kidney transplant recipients with crescentic glomerulonephritis	22
#623 SGLT2 inhibitors in adult patients with Alport syndrome: a single center Italian experience	22
#2190 The protective effects of a ketogenic diet in experimental glomerulonephritis are independent of the Hca2 receptor	21
#1644 Evaluation of clinical consequences in diverse forms of fistula elevation procedure	21
#3075 Comparison of β-blocker with other anti-hypertensive drugs in patients with chronic kidney disease in Korea: a national health insurance data	21
#3842 Significant association between B lymphocytes and their subpopulations with peripheral T follicular cells is evident in patients with systemic lupus erythematosus (SLE) at remission	21
#450 Comparison of Thymoglobulin® vs Grafalon® as induction treatment in kidney transplantation with maastricht type III donor	21
#3716 Change in mGFR following bariatric surgery: A case-crossover study	21
#2661 Interplay between polymorphism in the EDNRA gene and endothelin-1 concentration in the blood of patients with chronic kidney disease	21
#3389 Ultrasound evaluation of fluid overload in hemodialysis patients: comparison between VExUS score and lung ultrasound in a cross-sectional study	21
#1793 Renal protective effect of SGLT2 inhibitors in patients with Fabry disease	20
#1519 Granulomatous interstitial nephritis in a patient with metastatic melanoma on target therapy with dabrafenib and trametinib: a case report	20
#2491 Exploring the association between non-alcoholic fatty liver disease and chronic kidney disease: insights from NHANES 1999–2016	20
#3387 Hepatitis, acute kidney injury and myositis due to atorvastatin	20
#2980 Association between body mass index and nephrolithiasis markers in the Mexican population	20
#1100 “Unraveling the genetic complexity of autosomal dominant polycystic kidney disease: insights from gene conversion events”	20
#1795 Next-generation sequencing in chronic kidney disease of unknown etiology: a step toward precision medicine	20
#3480 Dehydration and hypertension differently prime intrinsic and pre-renal AKI	20
#3313 A novel identification of anti-hypertensive drug spironolactone as an inhibitor of paraoxonase 2 lactonase and anti-ROS activities	20
#2396 The potential of human-derived macrophages to study autosomal dominant polycystic kidney disease (ADPKD)	19
#1085 Acute kidney injury in Iraqi cancer patients treated with immune checkpoint inhibitors. (project ICI-AKI Iraq) interim analysis	19

#3225 Integrating telemedicine into peritoneal dialysis: a holistic model for palliative care in advanced CKD	19
#3368 The implementation of a multi-faceted cardio-renal service on heart failure and renal outcomes: a retrospective cohort study	19
#1715 Online prediction of dialysis adequacy failure in hemodialysis	19
#3692 Granulomatous interstitial nephritis and immunodeficiency—a link to remember	19
Cognitive deficits associate with cerebral hypoxia during hemodialysis	19
#3838 Hungry bone syndrome (HBS) as an outcome of parathyroidectomy as a treatment of hyperparathyroidism in a third level hospital in a medium-income country	19
#2782 Clinician usage and perception of an AI-based model predicting peritoneal dialysis dropouts	19
FHL2 in arterial medial calcification in chronic kidney disease	18
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis	18
#2984 SLE associated fibrillary glomerulonephritis vs SLE nephritis with fibrils: can a straightforward distinction always be made?	18
#1048 Why are felids at such a high risk of chronic kidney disease?	18
Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease	18
Teneligliptin and empagliflozin attenuate ferroptosis-mediated acute tubular injury	18
Transition of care of adolescent kidney transplant recipients—a call to action	18
Are patients with primary glomerular disease at increased risk of malignancy?	18
Plasma endotrophin, reflecting tissue fibrosis, is associated with graft failure and mortality in KTRs: results from two prospective cohort studies	18
Uromodulin biology	17
#560 The representation of multimorbidity and frailty in the development and validation of kidney failure risk prediction models – a systematic review	17
Management of heart failure in patients with kidney disease—updates from the 2021 ESC guidelines	17
#2528 APOL1 GENOTYPING AND PROTEINURIC KIDNEY DISEASE IN EUROPE	17
Clinical applications of artificial intelligence in autosomal dominant polycystic kidney disease	17
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy	17
Key enzyme in charge of ketone reabsorption of renal tubular SMCT1 may be a new target in diabetic kidney disease	17
Hippocampal subfield morphology in regular hemodialysis patients	17
Long-term lumasiran therapy final results from a Phase 2 open-label extension study in primary hyperoxaluria	17
Modeling podocytopathies with kidney organoids	17
Long-term outcome of kidney function in patients with ANCA-associated vasculitis	17
#1936 Investigating genetic and environmental modifiers of autosomal dominant polycystic kidney disease through a distinct PKD2-founder variant (p.Arg803*)	17
Non-crystalline light chain proximal tubulopathy, a morphologically protean entity	17
Global, regional and national burden of CKD in children and adolescents	17
#3848 ORIGIN TRIAL: 24-WK PRIMARY ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PH2B STUDY OF ATACICEPT IN PATIENTS WITH IGAN	17
Pediatric kidney care experience after the 2023 Türkiye earthquake	16
Towards carbon footprint measurement of the ERA Congress: five key strategies for greener events	16
Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport	16
#1685 Multimodal spatial profiling of microvascular inflammation in kidney allografts	16
Neutralizing the IL-7Rα limits injury in experimental ANCA-associated glomerulonephritis	16
CKD as a risk factor for severe COVID-19: a critical look back and lessons for the future	16
Intravenous methylprednisolone for nephrotic syndrome with minimal change lesions: a randomized controlled trial	16
On the fragility of outcome measures of two individual patient data analyses from randomized controlled trials on online haemodiafiltration	16
Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI	16
Age and gender differences in symptom experience and health-related quality of life in kidney transplant recipients: a cross-sectional study	16
Time trends in preemptive kidney transplantation in Europe: an ERA registry study	16
Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: biological challenges and clinical implications	16
Measuring quality of life in trials including patients on haemodialysis: methodological issues surrounding the use of the Kidney Disease Quality of Life Questionnaire	16
#4344 CHANGES IN ENERGY METABOLISM IN THE KIDNEY WITH TUBULOINTERSTITIAL FIBROSIS: AN EX VIVO WHOLE TISSUE 2D-COSY APPROACH	15
#6691 COMPREHENSIVE TWO-DAY IN-HOSPITAL ASSESSMENT MODE IS ASSOCIATED WITH THREE-YEAR AND FIVE-YEAR MORTALITY IN PERITONEAL DIALYSIS PATIENTS	15
#5093 DIALYSIS PATIENTS AND BNT162B2MRNA VACCINE TYPE ARE RISK FACTORS FOR IMMUNITY FADING 9 MONTHS AFTER SARS-COV-2MRNA VACCINATION (DIA-VACC STUDY)	15
#5341 EFFECTS OF URIC ACID-LOWERING THERAPY ON RENAL OUTCOMES IN CKD PATIENTS WITH ASYMPTOMATIC HYPERURICEMIA: A SYSTEMATIC REVIEW AND META-ANALYSIS	15
#5734 RENAL AUTOLOGOUS CELL THERAPY (REACT™) FOR DIABETIC CHRONIC KIDNEY DISEASE: PHASE II TRIAL WITH BILATERAL CORTEX INJECTIONS AND RE-DOSING TRIGGERS	15
#4735 USEFULNESS OF CYSTATIN C IN MEASURING RENAL FUNCTION AND PREDICTING METHOTREXATE ASSOCIATED TOXICITIES IN PATIENTS WITH RHEUMATOID ARTHRITIS	15
#3459 GLUCOSE-LOWERING THERAPIES IN END STAGE RENAL DISEASE: HOW CAN WE PREDICT THE RISK OF HYPOGLYCAEMIA?	15
#4494 DRUG UTILIZATION FOLLOWING INCIDENT CHRONIC KIDNEY DISEASE: AN OBSERVATIONAL STUDY IN THE UNITED STATES AND JAPAN	15
#3520 THE RELATIONSHIPS OF BONE TURNOVER MARKERS AND CEREBRAL WHITE MATTER ALTERATIONS IN PATIENTS UNDERGOING HEMODIALYSIS	15
#2067 Prediction of gastrointestinal bleeding hospitalization risk in hemodialysis using machine learning techniques	15
#832 Sickle cell trait and APOL1 high risk genotype increase the risk of ESKD similar to diabetes in British Africans	14
#1286 Utility of cinacalcet treatment in kidney transplant recipients with persistent hyperparathyroidism	14
#2999 APABETALONE REDUCES CARDIAC EVENTS IN CKD PATIENTS BY DOWNREGULATING FIBROTIC AND INFLAMMATORY PROCESSES	14
#2454 Meeting guideline goals at hemodialysis patients impact their survival?	14
#443 LEVIL evaluates the impact of HDx on HR-QoL and symptoms, including durability-of-effect and variability	14
#3865 TELEMEDICINE IN NEPHROLOGY: A CROSS-SECTIONAL STUDY	14
#6898 CATHETER RELATED BLOODSTREAM INFECTION IN NON-TUNNELED HEMODIALYSIS CATHETERS IN A RESOURCE-LIMITED HOSPITAL IN MERIDA, YUCATAN, MEXICO	14
#3163 SARS-COV-2 OMICRON INFECTIONS AMONG VACCINATED MAINTENANCE HEMODIALYSIS PATIENTS: OUTCOMES AND COMPARISON TO DELTA VARIANT	14
#228 APOL1 variants and chronic kidney disease in Morocco: case control study	14
#4100 ACUTE KIDNEY INJURY, GLOMERULONEPHRITIS AND TUBULOINTERSTITIAL NEPHRITIS FOLLOWING VACCINATION: VIGIBASE ANALYSIS	14
#58 SGLT2 inhibitor kidney outcome trials: under-representation of the majority of people with chronic kidney disease in real-world clinical practice	14
#5703 COVID-19, RENAL DAMAGE AND ITS EVOLUTION IN HOSPITALISED PATIENTS IN THE FIRST WAVE OF THE PANDEMIC: EXPERIENCE OF ONE CENTRE	14
#3989 INTERACTIVE-HD 2.0 PROJECT – PRELIMINARY RESULTS OF LUGANO DATASET	13
#4152 CROSS-OMICS PROFILING OF PROTEOME, METABOLOME, AND TRANSCRIPTOME REVEALS MOLECULE AND CLEARANCE DYNAMICS AND ORIGIN IN PERITONEAL DIALYSIS	13
#867 Calciprotein particles and phosphorus in conventional and extended-hours hemodialysis	13
#5613 ASSESSMENT OF THE PROGRESSION OF CKD TAKING INTO ACCOUNT METABOLIC CHANGES	13
#5213 RELATIONSHIP BETWEEN CYTOKINE RELEASE SYNDROME AND ACUTE KIDNEY INJURY AFTER CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY IN HEMATOLOGIC NEOPLASMS	13
#1454 Usefulness of the clinical frailty scale in Dutch patients with end-stage kidney disease	13
#1082 Early-stage chronic kidney disease as a risk factor for suicide: a nationwide observational cohort study	13
#3122 30-DAY COMPLICATIONS IN PERITONEAL DIALYSIS CATHETERS INSERTED PERCUTANEOUSLY VERSUS SURGICALLY IN A SECOND LEVEL HOSPITAL IN MERIDA, YUCATAN, MEXICO	13
#3956 PRIORITY OUTCOMES FOR EDUCATION AND SELF-MANAGEMENT IN NON-DIALYSIS CHRONIC KIDNEY DISEASE: A PATIENT AND PROFESSIONAL DELPHI SURVEY	13
#3435 UNPLANNED INITIATION OF HEMODIALYSIS IN ELDERLY PATIENTS WITH CHRONIC KIDNEY DISEASE: RISK FACTORS FOR SHORT TERM MORTALITY	13
#4204 MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING BIOMARKERS OUTPERFORM LAB BIOMARKERS FOR PREDICTING PROGRESSION OF DIABETIC KIDNEY DISEASE	13
#5686 CANCER STATUS AND MORTALITY IN ELDERLY INCIDENT HEMODIALYSIS PATIENTS	13
#1207 Post transplant diabetes mellitus in kidney transplanted patients: factors related and impact on long-term outcome	13
#3434 A FREE OPEN-SOURCE FRAMEWORK TO INFER PATIENT-LEVEL EGFR SLOPES FOR ASSOCIATION WITH MOLECULAR DATA	13
#5852 EFFECT OF DIET ON THE COLLECTOR DUCT BEHAVIOUR: RELEVANCE IN PRECLINICAL DRUG DEVELOPMENT	13
#6738 ALCOHOL LOCK IN CRBSI: A PANACEA	13
#4431 PREPARATION OF IMIDAZOLE QUATERNARY AMMONIUM SALT MICROSPHERES WITH HIGH BILIRUBIN ADSORPTION PERFORMANCE AND SELF-ANTICOAGULATION ABILITY	13
#1212 Trends in real-world lipid lowering therapy use among adult patients with chronic kidney disease: 5-year single center experience in the Philippines	13
#5128 PREDICTIVE FACTORS OF RENAL RECOVERY AND END-STAGE KIDNEY DISEASE IN PATIENTS WITH SEVERE ANCA-ASSOCIATED VASCULITIS WITH GLOMERULONEPHRITIS	13
#2293 Cardiac autonomic neuropathy: an independent risk factor for renal decline in diabetic kidney disease	13
#921 Interferon regulatory factor 4 (IRF4)-specific deletion on dendritic cells protects against kidney inflammation and injury in IRI-induced AKI/AKD	13
Self-reported health change in haemodialysis recipients modulates the effect of frailty upon mortality and hospital admissions: outcomes from a large prospective UK cohort	12
#1821 Baroflex sensitivity and hemodynamic responses during physical and mental tests: a comparative study between HD and PD patients	12
Long-term effect of COVID-19 infection on kidney function among COVID-19 patients followed in post-COVID-19 recovery clinics in British Columbia, Canada	12
Acute post-streptococcal glomerulonephritis in children—treatment standard	12
#1303 Hyperkalaemia-related RAASi reduction and estimated number needed to treat to avoid a first hospitalisation by maintaining RAASi	12
Eculizumab for pregnancy-related atypical hemolytic uremic syndrome	12
Peritoneal transformation shortly after kidney transplantation in pediatric patients with preceding chronic peritoneal dialysis	12
#784 Peritoneal dialysis-related infections by Kocuria kristinae: cases from a Mexican hospital	12